Highlights from the 2018 North American cystic fibrosis conference

Stacey L Martiniano; Cori L Daines; Elisabeth P Dellon; Charles R Esther Jr; Marianne S Muhlebach; Thida Ong; Elliot C Rabinowitz; Demet Toprak; Edith T Zemanick

doi:10.1002/ppul.24356

Highlights from the 2018 North American cystic fibrosis conference

Pediatr Pulmonol. 2019 Jul;54(7):941-948. doi: 10.1002/ppul.24356. Epub 2019 May 15.

Authors

Stacey L Martiniano¹, Cori L Daines², Elisabeth P Dellon³, Charles R Esther Jr³, Marianne S Muhlebach³, Thida Ong⁴, Elliot C Rabinowitz⁵, Demet Toprak⁴, Edith T Zemanick¹

Affiliations

¹ Department of Pediatrics, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, Colorado.
² Department of Pediatrics, University of Arizona College of Medicine, Tucson, Arizona.
³ Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
⁴ Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, Washington.
⁵ Department of Pediatrics, Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts.

PMID: 31091021
DOI: 10.1002/ppul.24356

Abstract

The 32nd annual North American Cystic Fibrosis Conference was held in Denver, CO on Oct. 18 to 20, 2018. This review highlights presentations in several topic areas, including the pathophysiology and basic science of cystic fibrosis lung disease, clinical trials, clinical care, and quality improvement. Citations from the conference are by first author and abstract or symposium number, as designated in the previously published supplement.

Keywords: cystic fibrosis.

Publication types

Congress

MeSH terms

Animals
Cystic Fibrosis* / physiopathology
Cystic Fibrosis* / therapy
Humans
Quality Improvement